Expert Shares at 52-Week Lows (TEVA, SE, PGH, VICL)

New York, NY -- (SBWIRE) -- 12/31/2012 -- Biotech concern TEVA (NYSE:TEVA) took a dive to the $36.75 level earlier today, marking its worst price in over 14 months. With today's pullback, the shares are now looking at an 8.6% drop for the year. In fact, TEVA's downtrend has been pressured by its 10-month and 20-month moving averages, which have acted as resistance since February 2011. TEVA's technical predicament has also begat bearishly biased sentiment, as half of the 26 covering analysts have handed out "hold" ratings.

How Should Investors React To TEVA Now? Find Out Here

Spectra Energy Corp (NYSE:SE) through its subsidiaries and equity affiliates, owns and operates a portfolio of complementary natural gas-related energy assets and is a natural gas infrastructure company. Spectra Energy operates in three areas of the natural gas industry: gathering and processing, transmission and storage, and distribution.Spectra Energy Co (NYSE:SE) is +0.12 - +0.45% from the previous close of $26.88. It traded between $26.55 - 27.04 with total traded volume of 1171426 shares. Keep a close eye on SE, as the stock has been showing unusual moves over the past weeks. At Current market price, SE has recovered +1.66% from its 52-week Low of 26.56 and has Pulled back -16.33% from its 52-week high of 32.27.

How Should Investors Trade SE Now? Click Here

Pengrowth Energy Corp (USA) (NYSE:PGH) declined 1.44% and closed at $4.80.The Market Cap of the Company is $2.43.billion.The Company announced that it has an agreement in place to sell its 10.01952% working interest in its non-operated Weyburn property to OMERS Energy Inc. and Ontario Teachers’ Pension Plan. Total proceeds from the agreement are expected to be $315 million. These funds will be used to finance the initial phase of the Lindbergh thermal bitumen project and used to reduce debt. Recently the Company also announced cash dividend of CAD0.04 per common share. The dividend will be payable to all shareholders who hold shares at the close of business on the record date of December 24, 2012.

Can PGH Continue To Move Higher? Find Out Here

Vical Incorporated (NASDAQ:VICL) shares decreased 6.95% and closed at $2.81. The company, last week, has licensed its patented Vaxfectin adjuvant to Cyvax, Inc., a vaccine development company, for use in malaria vaccines. Vaxfectin is an adjuvant with utility in infectious disease and cancer applications. It has been shown in multiple animal models to increase the antibody and T-cell immune responses to antigens expressed from DNA vaccines.

How Should Investors Trade VICL After The Recent Momentum? Find Out Here

DISCLAIMER
Neither PennyStocksUpdate.biz nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by PennyStocksUpdate.biz, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation.PennyStocksUpdate.biz makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through PennyStocksUpdate.biz. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned here in..

Contact:
PennyStocksUpdate.biz
info@pennystocksupdate.biz